ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Defibrillator Lead Performed Worse Than Competitor Lead -Study

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicenter study presented at a medical meeting Thursday. St. Jude stopped selling the Riata leads in 2010, but about 79,000 are still implanted in patients in the U.S. St. Jude said last year it was recalling them due to a tendency for the metal wires to wear through their silicone covering. Data in the study, presented at the Heart Rhythm Society meeting in Boston, was collected retrospectively from seven centers. Researchers evaluated the leads for all causes of failure, including cases where cables wore through their coating and electrical malfunctions. Riata, but not Riata ST, leads performed significantly worse than Quattro, according to the study. But follow-up for Riata ST was shorter than it was for Riata. The study also found that nearly a third of leads with exposed cables were malfunctioning. St. Jude said in a statement that the data is consistent with the company's findings that significant design changes implemented in the Riata ST leads resulted in improved performance compared to the Riata leads. In March, a study authored by Robert G. Hauser, a Minnesota cardiologist, tied a malfunction in Riata to at least 20 deaths. Dr. Hauser said the deaths alleged from Riata malfunctions were about nine times greater than Quattro. Last month, St. Jude said it was seeking a retraction of the study, published in the Heart Rhythm Journal. The company says Dr. Hauser undercounted deaths linked to Quattro. St. Jude shares were up 2.3% to $40.12 in recent trading. The stock is down 24% in the last year. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
08/29/201609:00:09Medtronic Technologies Improve Delivery of Cardiac Resynchronization...
08/28/201610:30:39New Long-Term Data Reinforce Safety Benefits of the World's Smallest...
08/26/201609:18:00Medtronic Files 8K - Increased Financial Obligation
08/26/201608:30:39Medtronic, on Behalf of Its Subsidiary Heartware International...
08/25/201609:45:00U.S. Hot Stocks: Hot Stocks to Watch
08/25/201608:30:00Medtronic Profit Rises, Helped by Lower Expenses
08/25/201606:50:45Current Report Filing (8-k)
08/25/201606:45:17Medtronic Reports First Quarter Financial Results
08/23/201608:54:05Medtronic Completes Acquisition of HeartWare International
08/19/201616:15:31Medtronic Announces Cash Dividend for Second Quarter of Fiscal...
08/17/201615:19:20Statement of Changes in Beneficial Ownership (4)
08/16/201609:00:24Medtronic to Announce Financial Results for Its First Quarter...
08/11/201607:00:15Medtronic Announces U.S. Launch of the MiniMed® 630G System...
08/10/201608:28:25Proxy Statement (definitive) (def 14a)
08/08/201609:00:17Medtronic Receives CE Mark for SureTune2(TM) for Deep Brain Stimulation...
08/03/201613:49:38Statement of Changes in Beneficial Ownership (4)
08/03/201613:47:42Statement of Changes in Beneficial Ownership (4)
08/03/201613:46:32Statement of Changes in Beneficial Ownership (4)
08/03/201613:45:40Statement of Changes in Beneficial Ownership (4)
08/03/201613:44:18Statement of Changes in Beneficial Ownership (4)

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad